Reaction: two analyses review efficacy of faecal transplants for treating ‘C. difficile’ infections and irritable bowel diseases
Faecal microbiota transplantation can be administered by oral capsules, colonoscopy or rectal enema, among other routes. Two meta-analyses evaluate its benefits and side effects for treating two types of disease. The first focuses on recurrent infections with Clostridioides difficile, a bacterium that can cause very severe diarrhoea; it includes six studies in Europe and North America involving 320 adults and concludes that in immunocompetent people, faecal transplantation is more effective than antibiotics. The second focuses on irritable bowel diseases, such as ulcerative colitis and Crohn's disease; it includes 12 studies with 550 participants and has less clear results.